IFP Advisors, Inc - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 254 filers reported holding SAGE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$13
-99.9%
820.0%0.00%
Q3 2022$13,0000.0%820.0%0.00%
Q2 2022$13,0000.0%820.0%0.00%
Q1 2022$13,000
+30.0%
82
-54.9%
0.00%
Q2 2021$10,000
-16.7%
182
+6.4%
0.00%
Q1 2021$12,000
-25.0%
171
-2.8%
0.00%
-100.0%
Q4 2020$16,000176
+5766.7%
0.00%
Q3 2020$030.00%
Q2 2020$0
-100.0%
0
-100.0%
0.00%
Q1 2020$1,000
-97.9%
23
-96.5%
0.00%
-100.0%
Q4 2019$48,000
-50.5%
660
-1.2%
0.00%
-33.3%
Q3 2019$97,000
+4750.0%
668
+5972.7%
0.01%
Q1 2019$2,000
-95.8%
11
-97.9%
0.00%
-100.0%
Q4 2018$48,000
-36.8%
534
-0.4%
0.00%0.0%
Q3 2018$76,000
-10.6%
536
-1.3%
0.00%
-25.0%
Q2 2018$85,000
+8400.0%
543
+10760.0%
0.00%
Q1 2018$1,0000.0%50.0%0.00%
Q4 2017$1,00050.0%0.00%
Q3 2017$050.0%0.00%
Q2 2017$050.0%0.00%
Q1 2017$050.0%0.00%
Q4 2016$050.0%0.00%
Q3 2016$0
-100.0%
5
-54.5%
0.00%
Q1 2016$2,000
+100.0%
11
-47.6%
0.00%
Q4 2015$1,000210.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Casdin Capital, LLC 312,000$29,886,0005.11%
DAFNA Capital Management LLC 104,306$9,991,0004.97%
Palo Alto Investors LP 850,977$81,515,0004.34%
BB BIOTECH AG 1,375,229$131,733,0004.22%
Eventide Asset Management 936,000$89,659,0003.97%
TRV GP II, LLC 37,362$3,579,0003.56%
KINGDON CAPITAL MANAGEMENT, L.L.C. 146,179$14,002,0002.11%
SUFFOLK CAPITAL MANAGEMENT LLC 111,908$10,720,0002.06%
OAK RIDGE INVESTMENTS LLC 231,483$22,174,0001.60%
Rhenman & Partners Asset Management AB 137,339$13,156,0001.50%
View complete list of SAGE THERAPEUTICS INC shareholders